Corbus Pharmaceuticals Holdings Inc (CRBP) stock has risen 14.17% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CRBP stock an overall score of 74 out of a possible 100.
That score is mainly influenced by a long-term technical score of 89. CRBP’s score also includes a fundamental score of 84. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of $24.75. This means analysts expect the stock to add 241.38% over the next 12 months. The short-term technical score for CRBP is 48.
What’s Happening with CRBP Stock Today
Corbus Pharmaceuticals Holdings Inc (CRBP) stock is down -2.77% while the S&P 500 is lower by -2.05% as of 3:22 PM on Tuesday, May 7. CRBP is lower by -$0.21 from the previous closing price of $7.46 on volume of 455,162 shares. Over the past year the S&P 500 has risen 7.48% while CRBP has risen 14.17%. CRBP lost -$0.98 per share in the over the last 12 months.